Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Early Earnings Season: Medical Devices Flat; Biopharmas Higher

publication date: Nov 13, 2009

Earnings season has now arrived, and China life science companies are reporting financial results from their most recent quarters. Although Mindray Medical, the medical device maker, announced a flat quarter, four small biopharmas had the pleasure of telling investors that revenues and profits are back on a significant upswing. All China life science companies may not follow this pattern, but it is a refreshing change to read earnings reports that do not have to mention the unsettled conditions caused by a worldwide financial crisis. More details...

Stock Symbols: (NYSE: MR)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here